I'm Davan Maharaj, editor of the Los Angeles Times. Here are some story lines I don't want you to miss today. TOP STORIES Popping the 'Pink Viagra' Pill After years of lobbying the Food and Drug Administration, women have an approved treatment for low sexual desire. Often called the “pink Viagra,” flibanserin is the first prescription drug certified for female patients with low libido. Many welcome the decision, but read why medical skeptics and those critical of drug companies’ influence have concerns. Old School, New School NBCUniversal, that old media conglomerate, has plunked down $200 million on BuzzFeed, the digital upstart.
Today: To Live Is to Fly
